A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

Clinical trial NCT06337032 · RECRUITING

Trial details

NCT number: NCT06337032
Sponsor: Gilead Sciences
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2024-08-27
Primary completion: 2034-03-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.